Key for crossing the BBB with nanoparticles: the rational design

Scholarly Works

• Negahdari, R.; Pouyanfar, N.; Masoudifar, R.; Aftabi, P.; Fendereski, F.; Anvari Rostami, Z.; Masoumi, N.; Faizi, M.; Ghorbani-Bidkorpeh, F. Nanoparticles and the gut-microbiome: a dual strategy for oral brain delivery. International journal of pharmaceutics 2026, 705, 127477. doi:10.1016/j.ijpharm.2026.127477
• Qi, X.-W.; Chen, Y.-H.; Zhang, Y.-T.; Li, J.; Hu, Z.-E.; Wang, J.-X.; Liang, C.-C.; Wang, Y.-F.; Li, J.; Li, B.-J.; Zhang, S. A Temporally Programmed Microneedles Platform for Long-Acting Regulation and Rapid Sensing of Systemic Copper Dyshomeostasis. Small (Weinheim an der Bergstrasse, Germany) 2026, e75829. doi:10.1002/smll.75829
• Chouhan, S. S.; Parashar, A. K.; Mahajan, T.; Sharma, Y.; Saraogi, G. K. Intranasal Drug Delivery for CNS Diseases: Challenges, Advances, and Future Directions. Current Pharmacology Reports 2026, 12. doi:10.1007/s40495-026-00477-8
• Sewell, P. E.; Jensen, C. Hyaluronidase-enhanced delivery in gene therapy and regenerative medicine for improved vector, cell, and cargo access. Frontiers in drug delivery 2026, 6, 1906950. doi:10.3389/fddev.2026.1906950
• Sahnoun, S. E. M.; Noristani, R.; Alimonti, P.; Pes, J.; Gubeljak, L.; Szymura, A.; Ilyas, S.; Arik, E.; Florea, A.; Buhl, E. M.; Neumaier, B.; Mathur, S.; Schulz, J. B.; Mottaghy, F. M.; Habib, P. Multifunctional theranostic nanocarrier platform for microglia-selective cytochalasin D delivery to modulate neuroinflammation after acute brain injuries. Biomaterials 2026, 337, 124495. doi:10.1016/j.biomaterials.2026.124495
• de Moraes, B. P. T.; da Silva, K. P.; Moraes-de-Souza, I. d.; Souza Gomes-Reis, G. L. d.; Saraiva, J. S. G.; Costa, M. F.; Cunha, C. M. C. d.; Almeida, M. A. P. d.; Guterres, S. S.; Pohlmann, A. R.; Immler, R.; Napoli, M.; Estato, V.; Bozza, P. T.; de Castro-Faria-Neto, H. C.; Ferrarini, S. R.; Sperandio, M.; Silva, A. R.; Gonçalves-de-Albuquerque, C. F. DHA-loaded nanocapsules enhance microcirculation and reduce inflammation in sepsis experimental model. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2026, 201, 119651. doi:10.1016/j.biopha.2026.119651
• Deng, L.; Li, H.; Yang, S.; Chen, F.; Qiao, J.; Bao, H.; Wang, X.; Fang, S.; Xu, B.; Tang, Z. Advances in nano-TCM for Alzheimer's disease: lipid-based carriers integrated with innovative delivery strategies. Journal of nanobiotechnology 2026, 24. doi:10.1186/s12951-026-04654-1
• Llorente, X.; Esteruelas, G.; García, M. L.; Souto, E. B.; Sánchez-López, E. Polymeric nanoparticles functionalized with peptides: Advanced strategies for crossing the blood-brain barrier. Advances in pharmacology (San Diego, Calif.) 2026, 105, 325–363. doi:10.1016/bs.apha.2026.03.002
• Li, X.; Li, J.; Sun, Y.; Yao, T.; Lu, Y.; Liu, S.; Li, H.; Shi, Y.; Chen, L.; Zhao, Y.; Jiang, W.; Li, Z.; Zhou, Z.; Wang, B.; Zhang, S.; Yu, H.; Lai, Y.; Lu, Q.; Li, Y.; Li, H.; Xu, Z.; Wang, G.; Zhu, Z. Engineering brain-penetrant PROTACs: Bridging molecular design and CNS delivery. Advanced drug delivery reviews 2026, 234, 115876. doi:10.1016/j.addr.2026.115876
• Naim, A.; Farooqui, A. M.; Badruddeen; Khan, M. I.; Akhtar, J.; Ahmad, A.; Ashique, S.; Islam, A. Nanoengineered phytochemicals overcome blood-brain barrier constraints in neurodegenerative disorders. Frontiers in neurology 2026, 17, 1792829. doi:10.3389/fneur.2026.1792829
• Li, Z.; Peng, Y.; Wang, Q.; Zhou, H.; Fu, X. Recent Advances in Stimuli-Responsive Iron Oxide Nanoparticles for Glioma Theranostics: Progress and Perspective. ACS Nano Medicine 2026, 1, 961–988. doi:10.1021/acsnanomed.5c00190
• Barra, T.; Bellotti, M.; Conti, M.; Auricchio, F.; Caimi, A.; Vestiti, M.; Chiesa, E.; Valiante, S. A dynamic in vitro model of blood-brain barrier: effect of different polymeric nanoparticles on the crossing ability. International journal of pharmaceutics 2026, 695, 126778. doi:10.1016/j.ijpharm.2026.126778
• Suryawanshi, T. Y.; Redkar, N.; Sharma, A.; Mishra, J.; Saxena, S.; Shukla, S. Nanobiotechnology-Based Strategies for Targeting Neuroinflammation and Neural Tissue Engineering. Immuno 2026, 6, 18. doi:10.3390/immuno6010018
• Zhao, Y.; Liu, C.; Zhang, X.; Gu, T.; Wang, Y.; Zuo, T.; Liu, S.; Xu, X.; Meng, H. Mechanistic and Strategic Insights into How Lipid Nanoparticles Interact with Membrane-Based Biological Barriers. ACS nano 2026, 20, 8971–9006. doi:10.1021/acsnano.5c21857
• Martinez-Martinez, N.; Carrera-Rodríguez, L.; Vargas, R.; Hernández-Munain, C.; Suñé-Pou, M.; Suñé, C. Brain delivery of lipid nanoparticles with shuttle peptides. Advances in pharmacology (San Diego, Calif.) 2026, 105, 257–323. doi:10.1016/bs.apha.2026.02.005
• Śledzikowska, Z.; Kubicka, D.; Makaruk, N.; Waszkiewicz, N. Gold nanoparticles for central nervous system drug delivery in depression: nanobiological mechanisms, pharmacokinetics and translational perspectives. Health Nanotechnology 2026, 2. doi:10.1186/s44301-026-00024-w
• Hernández-Bellido, N.; Hernández-Ainsa, S.; Köhler, R.; Ordovás, L. Nanotechnology-driven heart targeting to fulfil the potential of cardiac microRNA therapies. International journal of pharmaceutics 2026, 692, 126643. doi:10.1016/j.ijpharm.2026.126643
• Mouchtouris, N.; Amin-Hanjani, S. Pathophysiology of Cerebral Ischemia. Surgical and Interventional Treatment of Cerebral Ischemia; Springer Nature Switzerland, 2026; pp 17–21. doi:10.1007/978-3-032-08934-2_3
• Kumar, S.; Srivastava, S.; Tan, C. S.; Abohashrh, M.; Malviya, R. Correlation between oral disease and neurodegenerative disorders: Role of biological proteins for the modulation of oral-brain axis and gut-brain axis. Colloids and surfaces. B, Biointerfaces 2026, 262, 115480. doi:10.1016/j.colsurfb.2026.115480
• Patel, R.; Mevada, S.; Shukla, S.; Bhattacharya, S.; Alsaidan, O. A.; Prajapati, B. Carboxymethyl chitosan for neurological drug delivery: Current trends and future prospects. International journal of biological macromolecules 2026, 344, 150488. doi:10.1016/j.ijbiomac.2026.150488

Explore citations to this article at